10 Item(s)
per page

May 2017 Antibody UpdateMay 2017: The Antibody Update

In the May Antibody Update, you can expect to find news of an enzyme inhibitor that increases the efficacy of anti-PD-1 Immunotherapy, the generation of induced pluripotent blood stem cells, and the rapid employment of the latest Ebola vaccine in the Democratic Republic of the Congo. Learn more at ProSci.

Read More
Monday, June 5, 2017 3:37:34 PM America/Los_Angeles
Comments | Posted in News By Jonathan Felix

April 2017 Antibody UpdateApril 2017: The Antibody Update

In the April 2017 Antibody Update, ProSci presents to you a virucidal peptide found in the skin of frogs, evidence of new and hopeful RNA-drugs, and the innate immune systems role in congenital autoimmunity. 

 

Read More
Friday, May 5, 2017 12:17:25 PM America/Los_Angeles
Comments | Posted in News By Yousif Slaiwa

January 2017 Antibody UpdateJanuary 2017: The Antibody Update

The start of the new year has brought some interesting new stories in science and science policy. This Antibody Update looks at The Reproducibility Project's efforts in cancer drug research, changes to encourage vaccine development against less known, but still threatening viruses, and a new study on the mechanism of how macrophages cross the vascular endothelium.

Read More
Monday, February 6, 2017 9:09:09 AM America/Los_Angeles
Comments | Posted in News By Jonathan Felix

November 2016 Antibody UpdateDecember 2016: The Antibody Update

ProSci's last Antibody Update of 2016 includes the super effective Ebola vaccine developed by Merck, using the common diabetes drug metformin and the antihypertensive syrosingopine to combat cancer, and a link to a highlight review of the immune checkpoint TIGIT. Check it out!

Read More
Tuesday, January 3, 2017 10:00:00 AM America/Los_Angeles
Comments | Posted in News By Jonathan Felix

October 2016 Antibody UpdateNovember 2016: The Antibody Update

This months Antibody Update features the first use of CRISPR-Cas9 modified cells being used as therapeutics, the launch of the first vaccine against malaria, and the 21st Century Cures act, which may vastly increase funding of public health agencies for the next decade. Learn more here.

Read More
Wednesday, November 30, 2016 10:30:41 AM America/Los_Angeles
Comments | Posted in News By Jonathan Felix

ProSci's HIV ResearchProSci's HIV Research

ProSci has devoted the last several years to the development of a vaccine for HIV. This blog is a summary of where our research started, what we have accomplished, and where our future research is heading.




Read More
Friday, August 12, 2016 5:17:32 PM America/Los_Angeles
Comments | Posted in Research Highlights By Jonathan Felix

ProSci Blog Antibody Update June 2016

July 2016: The Antibdy Update

This Antibody Update's news includes the discovery of a new MRSA antibiotic found in the nose, the newest map of the human brain, and the discovery of a neutralizing antibody against the highly conserved HA stalk of inluenza. Check it out on ProSci's blog.


Read More
Wednesday, August 3, 2016 11:00:00 AM America/Los_Angeles
Comments | Posted in News By Jonathan Felix

ProSci Antibody UpdateApril 2016: The Antibody Update

This months news features a new study on broadly neutralizing antibodies long term treatment of HIV, where the first reported Zika Virus death in US territory occured, and a fully human polyclonal antibodies against Ebola-Z. For more detail checkout this month's Antibody Update.

Read More
Tuesday, May 3, 2016 10:00:00 AM America/Los_Angeles
Comments | Posted in News By Jonathan Felix

ProSci Antibodies

ProSci's Antibody Expert's Published in Vaccine!

Last month, the latest ProSci research on the HIV vaccine development was published in the scientific journal Vaccine. Here is a background on the work ProSci has done developing a vaccine against the HIV glycoproteins.

 


Read More
Thursday, September 17, 2015 3:06:40 PM America/Los_Angeles
Comments | Posted in Research Highlights By Jenny Mai
AP PROVIDES ACCESS TO THIS PUBLICLY DISTRIBUTED HANDOUT PHOTO PROVIDED BY NIAID; MANDATORY CREDIT: NIAID   Results from a new trial found that an "extremely potent" antibody can dramatically reduce the level of the HIV virus in a patient's blood.
Read More
Thursday, April 30, 2015 5:08:26 PM America/Los_Angeles
Comments | Posted in Science Corner By Anhao Sam
10 Item(s)
per page